Back to Journals » ImmunoTargets and Therapy

ImmunoTargets and Therapy

COPE logo
ISSN: 2253-1556

Journal Image

Editor-in-Chief: Professor Michael R Shurin

ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 


This journal offers Accelerated Publication.

 

Latest articles:

- 5 records -

Myeloid Cell-Derived Thrombospondin-1 Mediates Anti-Metastatic Effects of Histamine Dihydrochloride in B16 Melanoma

Issdisai N, Kaya M, Hellstrand K, Grauers Wiktorin H, Martner A

ImmunoTargets and Therapy 2026, 15:596703

Published Date: 6 June 2026

Integrin alpha8beta1 is Identified as a Potential CAR-T Target for BCMA-Resistant Relapsed Multiple Myeloma

Liu S, Wu J, Liu J, Wu K, Huang Y, Geng S, Wang Y, Weng J, Du X, Lai P

ImmunoTargets and Therapy 2026, 15:605729

Published Date: 28 May 2026

The Immune Architecture of Eosinophilic Esophagitis: Mechanisms, Therapeutic Targets, and Precision Management

Bertin L, Caldart F, Barchi A, Seregni N, Pasta A, Calabrese F, Marabotto E, Mari A, Farah A, Sirinic E, Sorge A, Ghisa M, Chahuán J, Savarino V, Savarino EV

ImmunoTargets and Therapy 2026, 15:510865

Published Date: 27 May 2026

Comprehensive Review of Immunotherapy in Colorectal Cancer: From Mechanisms to Nursing Interventions

Zhu Q, Lai Y, Zhao J, Zhang Z, Cui X, Kou M

ImmunoTargets and Therapy 2026, 15:603959

Published Date: 27 May 2026


Read more articles